TytoCare, Vivaz and Nebula team up to bring innovative virtual care to Spain


Live, spain Leading Digital Healthcare Provider, Introduces TytoCare’s Virtual Primary Care Solution to Strengthen Healthcare Options, Primary Care Access and Quality Across the Lifespan Spain

TEL AVIVIsrael , September 15, 2022 /PRNewswire/ — TytoCarethe global healthcare industry’s first modular all-in-one device and exam solution for AI-powered remote physical exams, today announced a partnership with livethe health insurance brand of Línea Directa Aseguradora, one of the leading health insurers in Spain, to bring the TytoCare solution to the Spanish market. Vivaz will integrate TytoCare into its current offering, enabling clinical-grade primary care anywhere, anytime. TytoCare will be distributed by Nebula-VPCa major healthcare distributor in the Spanish market.

Emergency Services (ED) through Spain are overwhelmed by a large number of unnecessary and avoidable visits, leading to long lines, overcrowded medical facilities and long waiting times for medical care. Virtual care offers an alternative, meeting primary care needs and beyond with immediate and “always on” care from any location. While traditionally telemedicine in Spain involves a simple phone or video call with a doctor, TytoCare goes far beyond, using a simple, all-in-one diagnostic tool to generate accurate patient information and deliver high-quality medical services at all times. , anywhere. Vivaz customers can now access primary care visits remotely via TytoCare TytoHome solution, replicating an in-person doctor visit from the comfort of home with comprehensive remote exams resulting in diagnoses.

“Our customers through Spain will benefit from this truly revolutionary new access to high quality, convenient and digital care in their daily lives,” said Olga Moreno, CEO of Vivaz. “Families are making unnecessary and time-consuming trips to overcrowded, germ-filled emergency departments for issues that could easily be resolved by a primary care physician if appointments with clinicians were more readily available. We are thrilled to expand our digital offerings through our partnership with TytoCare, using their all-in-one solution to provide comprehensive exams, without the hassle of going to the hospital.”

TytoCare’s CE Mark Approved Portable Examination Kit allows users to perform comprehensive physical examinations of the heart, skin, ear, throat, abdomen, and lungs, and measure heart rate heart rate and body temperature, which are essential for the treatment of many acute and chronic conditions. This enables healthcare clinicians to obtain the vital clinical data needed to monitor, diagnose and treat patients remotely. This level of comprehensive virtual care translates into increased customer loyalty and retention, and reduces unnecessary and avoidable ER visits, driving down costs for insurers and creating a win-win situation for patients and caregivers. payers.

“We are excited to enter the Spanish market through Nebula-VPC with a forward-thinking digital partner like Vivaz,” said Dedi Gilad, CEO and co-founder of TytoCare. “As emergency departments struggle to meet the massive demand for daily care, we are excited to provide patients with virtual care that allows them to skip the waiting room and still receive a diagnosis, thus eliminating the guesswork for physicians and enabling virtual care to go beyond simple video and audio solutions.”

“Through this partnership, Spaniards will now – for the very first time – have access to virtual care that truly meets all their medical and personal needs,” said José María Cucho, CEO of Nebula-VPC. “We look forward to continuing to improve care in Spain through innovation and better access to quality care.

About TytoCare

TytoCare is a telehealth company that uses AI to transform primary care by putting health in the hands of consumers. TytoCare seamlessly connects people with clinicians to provide the best in-home virtual examination and diagnostic solutions. Its solutions are designed to allow a complete medical examination from any location and include an all-in-one portable tool to examine the heart, lungs, skin, ears, throat, abdomen and body temperature. ; a comprehensive telehealth platform for sharing exam data, performing live video exams and scheduling visits; a cloud-based data repository with analytics; and integrated guidance technology and machine learning algorithms to ensure accuracy and ease of use for patients and insights for healthcare providers. Co-founded by Dedi Gilad and Ofer Tzadik in 2012, TytoCare obtained FDA and CE clearances and partnered with more than 180 major health systems, health plans and strategic partners in the United States, Europe, Asia, Latin Americaand Israel. To watch a demonstration video, click here.

For more information, please visit https://www.tytocare.com/.

TytoCare Press Contact

Allison Gray
Main media
[email protected]
United States: +1 323 283 8176
UK: +44 203 807 4482

About Vivaz

Vivaz is the health insurance brand of Línea Directa Aseguradora SA. It is an innovative, easy-to-use health insurance with a good quality-price ratio, which focuses on the integral care of the health of its customers. Vivaz has a medical directory made up of more than 30,000 health professionals and 1,000 health centers. In addition, it was the first health insurance in Spain which rewarded its customers for following a healthy lifestyle with direct discounts on the price of their insurance policies.

Vivaz Press Contact

Santiago Velázquez
External Communication Manager
[email protected]
ES: +34 682 19 69 53

About Nebula-VPC

Nebula is a leading company in implementing virtual primary care systems to reduce harmless emergencies and improve patient quality of life.

Press Contact Nebula-VPC

Sergio Iborra Varela
Administrator
[email protected]
ES:+34 669 69 14 87

Quote

Show original content:https://www.prnewswire.com/news-releases/tytocare-vivaz-and-nebula-partner-to-bring-innovative-virtual-care-to-spain-301625078.html

SOURCETyto Care

Previous BR financial analyst reacts to the Cut Inflation Act
Next Remarks by the Director-General of WHO during the quarterly PRSEAH briefing with Member States - 15 September 2022